← Devices & Neurotechnology
Details checkedClinical trial listing onlyCheckedregistry
Dartmouth Hyperbaric Oxygen Emerging-Indications Study
Also known as: 100% Oxygen, Hyperbaric oxygen treatment (HBOT), HBO2, Emerging Indications for Hyperbaric Oxygen Treatment, NCT07240649
Investigator-led study
Sponsor / Institution
Investigator-led study
Program Type
Device
Modality
Drug Delivery
Stage
Phase 4
Status
Active
Target Gene
—
Route / Mode
Hyperbaric oxygen chamber delivering 100% oxygen under pressure
Confidence
82%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
United States
Population
adult, tinnitus, broad-emerging-indications
Trial IDs
1
Mechanism
Broad not-yet-recruiting Phase 4 study of hyperbaric oxygen treatment for many emerging indications, including tinnitus as one listed condition.
Indications
Notes
Verified as a broad hyperbaric-oxygen emerging-indications registry record with tinnitus listed among many conditions. HearScape should present this as hearing-adjacent and not as a focused tinnitus therapeutic program.
Evidence & Sources
1 structured sourcesclinicaltrials
Supports: canonicalName, aliases, company, allCompanies, isIndustrySponsored, programType, modality, mechanism...
IDs: NCT07240649
Key Events
Clinical Trials (1)
Data Checks
investigator-led-studyregistry-only-evidencenot-yet-recruitingbroad-multi-indication-studyhearing-adjacent-record
Related Programs
Lenire Tinnitus Treatment Device
Company: Neuromod Devices · Neuromodulation · Marketed
Auricle Tinnitus Device
Company: Auricle Inc. · Neuromodulation · Phase 2
Neuromonics Tinnitus Treatment System
Company: Neuromonics · Neuromodulation · Marketed
Tinearity G1 Tinnitus System
Company: Duearity · Neuromodulation · Marketed
Beltone Serene Hearing Aids
Company: Beltone · Hearing Aid/Software · Marketed
Signia Notch Therapy
Company: Signia · Neuromodulation · Marketed